🇺🇸 FDA
Patent

US 7226589

Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor

granted A61KA61K31/70A61K39/00

Quick answer

US patent 7226589 (Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/70, A61K39/00, A61K47/6957, A61K48/00